drugset / Trial / NCT06823947
Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension
RandomizedSequentialTriple-blindTreatment
Summary
Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.
Timeline
- Start
- 2025-04-03
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KK3910 | Unknown | — | Subcutaneous |